Key Takeaways
- Multimodal imaging uses multiple imaging techniques together — chest X-rays, CT scans, PET scans, and MRIs — to diagnose mesothelioma non-invasively. Using several techniques creates a “safety net” that catches what any single test might miss.
- Chest X-rays are typically the first step — they can detect masses in the lungs but cannot determine whether a mass is cancerous, benign, or fatty tissue.
- CT scans provide more detail — they can detect tumors in the chest wall, pleural effusions, and thickening of the pleura (which occurs in approximately 90% of mesothelioma patients).
- PET scans complement CT scans by helping doctors determine the cause of pleural thickening — they are approximately 89% effective at differentiating mesothelioma from other diseases.
- MRIs locate invasion of the chest wall and can create 3D reconstructions of tissues, bones, and organs for detailed surgical planning.
- While a biopsy remains the gold standard for definitive diagnosis, multimodal imaging can significantly decrease diagnosis time — and earlier diagnosis is directly associated with better outcomes and improved prognosis.
How is Mesothelioma Diagnosed?
There isn’t a single way of diagnosing mesothelioma; rather, it often takes a multitude of
diagnostic measures for a definitive diagnosis. Because mesothelioma symptoms present in
advanced stages, it’s critical for doctors to proceed with urgency, a keen attention to detail, and
an esteeming of patient symptoms. Oftentimes, doctors use biological markers as proxies for
mesothelioma—for instance, certain immune system “red flags” or an irregular chest X-ray—but
the only surefire way to diagnose is through a biopsy, or a sample of living tissue. Currently,
visualization techniques do not suffice as diagnostic tools, especially because mesothelioma is
relatively rare (~3,000 new cases in the U.S. a year).
What is Multimodal Imaging?
Multimodal imaging refers to the ways that doctors non-invasively screen for mesothelioma, as
used in conjunction. Multimodal imaging is useful—more useful than a standalone imaging
technique—because they analyze different bodily systems, and therefore, different ways that
mesothelioma can manifest. A factor contributing to the difficulty of a mesothelioma diagnosis is
that mesothelioma tends to be heterogeneous in nature, i.e., different parts of the same tumor
look, behave, and grow differently. Multimodal imaging acts like a safety net for this
heterogeneity: if one technique doesn’t catch mesothelioma, then another technique is likely to.
Some Constituents of Multimodal Imaging Include:
Chest X-Rays are usually the first course of action, given their accessibility and ability to detect
masses in the lungs and surrounding tissues. X-rays do not differentiate between types of masses,
so there’s no way to discern whether a mass is fatty or cancerous, let alone malignant or benign.
CT scans are able to detect tumors in the chest wall, the instance of pleural effusions, or the
thickening of the pleura (membrane surrounding the lungs, which is affected by mesothelioma).
Thickening of pleura occurs in ~90% of mesothelioma patients, so this is another “proxy” of
diagnosis without biopsy certification. Plus, CT scans are more accurate than x-rays, as the chest
wall can be visualized without obstructions. This is an example of multimodal imaging: first
using an X-ray to establish the presence of masses, but pivoting to CT scans to visualize the type
and spread of the mass.
PET scans are a complement to CT scans, which initially visualized the thickening of the pleura.
PET scans can help doctors discern the cause of said thickening, which can be attributable to
factors beyond mesothelioma. Because of this, PET scans are about 89% effective in
differentiating between mesothelioma and other diseases.
MRIs are useful for their capacity to locate invasion of the chest wall, as well as create a 3D
reconstruction of the body’s tissues, bones, and organs.
Even though biopsy is the gold-star standard of mesothelioma diagnosis, multimodal imaging
(especially for patients with known asbestos exposure) can help decrease diagnosis time and
speed up the treatment process. Earlier diagnosis is associated with better patient outcomes and
increased prognosis, so establishing multimodal techniques as credible is important.
If you or a loved one has been diagnosed with mesothelioma, please call 1 (800)-505-6000 or fill
out our form. We are here to help you navigate the legal process of filing a claim to receive
compensation for your mesothelioma diagnosis. We help mesothelioma victims and their
families in Pennsylvania.
Frequently Asked Questions
What is multimodal imaging for mesothelioma?
Multimodal imaging is the practice of using multiple imaging techniques together — such as chest X-rays, CT scans, PET scans, and MRIs — to diagnose mesothelioma. Each technique analyzes different aspects of the body, and when used in combination, they provide a more complete diagnostic picture than any single test alone. This is especially important because mesothelioma tumors are heterogeneous — different parts of the same tumor can look, behave, and grow differently — making them easy to miss with a single imaging method.
How does each imaging technique contribute to diagnosis?
Each technique plays a specific role in the diagnostic process:
- Chest X-ray — the first step, used to detect the presence of masses in the lungs and surrounding tissues. Cannot distinguish between cancerous and non-cancerous masses.
- CT scan — provides detailed cross-sectional images that can identify tumors in the chest wall, pleural effusions, and pleural thickening (present in ~90% of mesothelioma patients).
- PET scan — complements CT by determining the cause of pleural thickening. Approximately 89% effective at distinguishing mesothelioma from other conditions.
- MRI — locates chest wall invasion and creates 3D reconstructions of tissues and organs for detailed treatment planning.
The progression from X-ray to CT to PET to MRI represents an increasingly detailed and accurate diagnostic pathway.
Why is mesothelioma so difficult to diagnose with imaging alone?
Several factors make imaging-only diagnosis challenging. Mesothelioma is heterogeneous — different areas of the same tumor can look and behave differently, so a single imaging technique may only capture part of the picture. The cancer also doesn’t always form a distinct mass — it often spreads across the pleural lining in a diffuse pattern that can be missed or mistaken for other conditions. Additionally, mesothelioma is rare (~3,000 U.S. cases/year), so it may not be the first condition doctors suspect when reviewing imaging results.
Is a biopsy still necessary if imaging suggests mesothelioma?
Yes. A tissue biopsy remains the gold standard for definitive mesothelioma diagnosis. Imaging techniques can strongly suggest mesothelioma — especially when multiple modalities point in the same direction — but only a biopsy can confirm the diagnosis at the cellular level, identify the specific cell subtype (epithelioid, sarcomatoid, or biphasic), and rule out other cancers. However, multimodal imaging is valuable because it can speed up the diagnostic process, guide biopsy placement for more accurate sampling, and help with staging and treatment planning.
What does it mean that pleural thickening occurs in 90% of mesothelioma patients?
Pleural thickening — a measurable increase in the thickness of the membrane lining the lungs — is one of the most common detectable signs of pleural mesothelioma. The fact that it appears in approximately 90% of patients makes it a reliable indicator on CT scans. However, pleural thickening can also be caused by other conditions (infection, inflammation, other cancers), which is why a PET scan is used as a follow-up to determine whether the thickening is specifically caused by mesothelioma. The PET scan’s 89% accuracy in making this distinction is what makes the CT-to-PET progression so valuable.
Why does earlier diagnosis improve mesothelioma outcomes?
Mesothelioma is an aggressive cancer with a limited treatment window. Patients diagnosed at earlier stages have access to a wider range of treatment options — including potentially curative surgeries like pleurectomy decortication — that are no longer available once the cancer has spread. By the time symptoms appear, the cancer is often already advanced. Multimodal imaging can help identify mesothelioma before it reaches later stages, particularly in patients with known asbestos exposure who are being monitored proactively.
What should I do if I have a history of asbestos exposure?
If you have a known history of asbestos exposure, inform your doctor and ask about proactive monitoring — including regular imaging and blood tests for mesothelioma biomarkers. Early detection through multimodal imaging can make a significant difference in treatment options and prognosis. If you or a loved one has been diagnosed with mesothelioma, call (800) 505-6000 or fill out our contact form for a free consultation.
Sources:
National Library Of Medicine 1
National Library Of Medicine 2
